Extended surgical resection in T4 gastric cancer

Extended surgical resection in T4 gastric cancer
复制标题

DOI:
10.1016/s0002-9610(97)00268-7
复制
发表时间:
1998-02-01
影响因子:
3
通讯作者:
Evans, SRT
Evans, SRT
中科院分区:
医学3区
文献类型:
--
作者:
Shchepotin, IB;Chorny, VA;Evans, SRT

文献摘要

被引文献

相似文献

背景技术背景:一些医生仍然认为胃癌侵犯邻近器官是不可治愈的疾病的征兆。方法:回顾性分析了353例T-4胃癌患者行联合胃切除术的情况。237例(67.1%)患者行胃大部切除术,116例(32.9%)患者行全胃切除术。最常与胃一起切除的器官为横结肠159例(45%),胰尾和脾150例(42.5%),肝左叶101例(28.5%),胰头37例(10.5%)。在该患者亚组中共发生110例术后并发症,并发症发生率为31.2%。该患者亚组中共发生48例术后死亡,死亡率为13.6%。所有接受联合胃切除术的患者的5年生存率为25%。淋巴结阴性的T-4胃癌切除术,37%存活5年,而T-4淋巴结阳性切除术只有15%5-year survival.CONCLUSIONS:T-4胃癌患者(约20%的患者)将受益于积极的块手术切除术,不应被视为不可切除。(C)1998年,Excerpta Medica,Inc.
BACKGROUND: Some physicians still consider invasion of adjacent organs by the carcinoma of stomach as a sign of incurable disease.METHODS: This retrospective study has been done with particular reference to 353 T-4 gastric cancer patients who underwent combined gastrectomies with adjacent organs.RESULTS: Subtotal gastrectomy was performed in 237 (67.1%) patients and total gastrectomy was performed in 116 (32.9%) patients. Organs most commonly resected with the stomach were the transverse colon in 159 (45%) cases, the tail of pancreas and spleen in 150 (42.5%), the left lobe of liver in 101 (28.5%), and the head of pancreas in 37 (10.5%) patients. A total of 110 postoperative complications occurred in this subset of patients corresponding to a complication rate of 31.2%. A total of 48 postoperative deaths occurred in this subset of patients corresponding to a mortality rate of 13.6%. The 5-year survival rate for all patients who underwent combined gastrectomy with adjacent organs was 25%. Of the node-negative T-4 gastric cancer resections, 37% survived 5 years whereas the T-4 node-positive resections have only a 15% 5-year survival.CONCLUSIONS: Patients who present with T-4 gastric cancer (about 20% of the patient population) will benefit from aggressive on bloc surgical resection and should not be considered unresectable. (C) 1998 by Excerpta Medica, Inc.